- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about AWKNF
Recent news which mentions AWKNF
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
From Benzinga
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
August 19, 2022
From Benzinga
Awakn's Second Licensing Partnership Agreement In A Week, This Time In Canada: Ketamine For Pain Comorbidities
August 18, 2022
Tickers
AWKNF
From Benzinga
Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
August 16, 2022
From Benzinga
From Benzinga
Michael Pollan's 'How To Change Your Mind' Now On Netflix, Here Are Reactions From Experts
July 14, 2022
From Benzinga
UK To Fund Development Of Awakn's Ketamine-Assisted Therapy Program For Alcohol Use Disorder In US And UK
July 05, 2022
Tickers
AWKNF
From Benzinga
Michael Pollan's 'How To Change Your Mind' Coming Soon To Netflix: Documentary Based On Psychedelics Best Seller
June 17, 2022
From Benzinga
From Benzinga
From Benzinga
Awakn Life Sciences Reports Completing World's First Ketamine Study For A Range Of Behavioral Addictions
May 24, 2022
Tickers
AWKNF
From Benzinga
Awakn's Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research
May 19, 2022
Tickers
AWKNF
From Benzinga
From Benzinga
Core One Labs Begins Trading On OTCQB
April 06, 2022
From Benzinga
Psyched: Atai, MindMed, Enveric and Mydecine Release 2021 Earnings, Bienstar Expands To Brazil & More!
April 06, 2022
From Benzinga
Stifel Initiates Coverage On Awakn Life Sciences With A Speculative Buy, $8 Target Price Target
April 04, 2022
Tickers
AWKNF
From Benzinga
From Benzinga
Awakn Life Sciences Seeks To Treat Addictions: Gambling, Binge Eating And Compulsive Sexual Behavior
March 28, 2022
Tickers
AWKNF
From Benzinga
This Ketamine-Assisted Therapy Company Is Developing New Ways To Treat Alcohol Addiction
March 24, 2022
From Benzinga
Mindset Pharma, Cybin Among Top Psychedelic Movers Of Today
February 08, 2022
From Benzinga
Mind Medicine, Allied Among Top Psychedelic Movers Of Today
February 02, 2022
From Benzinga
Mind Medicine, Small Pharma Among Top Psychedelic Movers Of Today
January 27, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 24, 2022
January 24, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 21, 2022
January 21, 2022
From Benzinga
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
From Benzinga
From Benzinga
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.